National and Kapodistrian University of Athens
Γενετικοί πολυμορφισμοί του άξονα ρενίνης - αγγειοτασίνης - αλδοστερόνης σε σχέση με την ανταπόκριση της αρτηριακής πίεσης στην αναστολή του μετατρεπτικού ενζύμου της αγγειοτασίνης ή τον αποκλεισμό των τύπου 1 υποδοχέων της αγγειοτασίνης
Abstract
dc:descriptionThis study aimed to investigate the association between ι) polymorphisms of the angiotensin converting enzyme (ACE)angiotensinogen (AGT) angiotensin type-1 receptor (ATiR) and adducin (ADC) genes and ιι) the antihypertensive responseto ACE inhibition and ATiR blockade Thirty two untreated hypertensives were randomized to receive for 5 weeks the ATiRblocker telmisartan (80 mg) or the ACE inhibitor lisinopnl (20 mg) Patients were then crossed-over to the alternativetreatment for a second 5 week penod Twenty four hour ambulatory blood pressure (ABP) was measured beforerandomizatjon and on the final day of each treatment penod (study 1) The same cross-over design was used in a study on27 untreated hypertensives randomized to the ATiR blocker losartan (50 mg) or lisinopnl (20 mg) (study 2) Polymerasechain reaction was used for the asserire·1* ο* the fc' owing gene polymorhisms ACE insertion/deletion AGT MT235 ATiRA1166C and ADC Gly460Trp Subjects were classified as responders and nonresponders using as a threshold an arbitrarylevel of response (diastolic ABP fall >10 mm Hg) or the median ABP response achieved by each of the drugs Theassociation between polymorphisms and BP response was examined by one-way analysis of variance and multiplecontingency table analysis No difference was detected between lisinopnl and telmisartan in their effect on ABP in study 1(mean difference 1 2±7 1 95% CI 14 38 mmHg [systolic]/0 7±5 1 95% CI 12 2 5 mmHg [diastolic]) whereas lisinopnlwas more effective than losartan in reducing ABP in study 2 (mean difference 5 1±8 5 95% CI 1 7 8 5 mmHg p<0 01[systolic]/3 5±6 1 95% CM 1 5 9 mmHg p<0 01 [diastolic]) Differences in average ABP decline between polymorphism subgroups were non significant for all 4 genes studied for both systolic and diastolic BP in both studies No specific patternof genotyping was detected for responders and non responders to each drug whereas no association was found in thegenotyping pattern of responders to lisinopnl between the two studies There seems to be no significant association betweenthe investigated genotypes and the ABP response to ACE inhibition or ATiR blockade Moreover no specific genotypingprofile appears to charactenze responders and non responders to these two drug classesnapoc>-
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Eustathiou, Stamatios
- Ευσταθίου, Σταμάτιος
Subjects
dc:subject × 18- Αρτηριακή πίεση
- Υπέρταση
- Αναστολείς μετατρεπτικού ενζύμου
- Ανταγωνιστές υποδοχέων αγγειοτασίνης
- Γονίδια
- Πολυμορφισμοί
- Σύστημα ρενίνης-αγγειοτενσίνης
- Blood pressure
- Hypertension
- Angiotensin converting enzyme inhibitors
- Angiotensin receptor blockers
- Genes
- Polymorphisms
- Renin-angiotensin system
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24928